Candidates for tumor markers of cervical cancer discovered by proteomic analysis

Journal of Korean Medical Science

Volumn 27, Issue 12, 2012, Pages 1479-1485

  Song, Jae Yun ^a   Bae, Hyo Sook ^a   Koo, Do Hyoung ^a   Lee, Jae Kwan ^a   Jung, Hak Hyun ^a   Lee, Kyu Wan ^a   Lee, Nak Woo ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Cervical cancer; Matrix assisted laser desorption ionization time of flight mass spectrometry; Two dimensional polyacrylamide gel electrophoresis

Indexed keywords

CYCLIN DEPENDENT KINASE 4; FATTY ACID BINDING PROTEIN; NCK PROTEIN; ONCOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ARTICLE; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; TWO-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

CERVICAL CANCER; MATRIX ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT MASS SPECTROMETRY; TWO-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE 4; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84872527141     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.12.1479     Document Type: Article

References (29)

1. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, Park EC, Lee JS. Cancer statistics in Korea: Incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010; 25: 1113-21.
2. Chung HH, Jang MJ, Jung KW, Won YJ, Shin HR, Kim JW, Lee HP. Cervical cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer 2006; 16: 1833-8.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
4. Kim MA, Oh JK, Kim BW, Chay D, Park DC, Kim SM, Kang ES, Kim JH, Cho CH, Shin HR, et al. Prevalence and seroprevalence of low-risk human papillomavirus in Korean women. J Korean Med Sci 2012; 27: 922-8.
5. Molina R, Filella X, Auge JM, Bosch E, Torne A, Pahisa J, Lejarcegui, JA, Rovirosa, A, Mellado B, Ordi J, et al. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. Anticancer Res 2005; 25: 1765-71.
6. Urquiza M, Guevara T, Espejo F, Bravo MM, Rivera Z, Patarroyo ME. Two L1-peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions. Biochem Biophys Res Commun 2005; 332: 224-32.
7. Nguyen GK, Nguyen-Ho P, Husain M, Husain EM. Cervical squamous cell carcinoma and its precursor lesions: cytodiagnostic criteria and pitfalls. Anat Pathol 1996; 1: 139-64.
8. Orsmark C, Skoog T, Jeskanen L, Kere J, Saarialho-Kere U. Expression of allograft inflammatory factor-1 in inflammatory skin disorders. Acta Dermato-Venereol 2007; 87: 223-7.
9. Iris FJ, Bougueleret L, Prieur S, Caterina D, Primas G, Perrot V, Jurka J, Rodriguez-Tome P, Claverie JM, Dausset J, et al. Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilo-base HLA class III segment. Nat Gen 1993; 3: 137-45.
10. Kimura M, Kawahito Y, Obayashi H, Ohta M, Hara H, Adachi T, Tokunaga D, Hojo T, Hamaguchi M, Omoto A, et al. A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 2007; 178: 3316-22.
11. Liu S, Tan WY, Chen QR, Chen XP, Fu K, Zhao YY, Chen ZW. Daintain/ AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci 2008; 99: 952-7.
12. Vartiainen MK, Machesky LM. The WASP-Arp2/3 pathway: genetic insights. Curr Opin Cell Biol 2004; 16: 174-81.
13. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004; 64: 8585-94.
14. Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, Kato H, Matsuoka T, Mukai K. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res 2006; 12: 2449-54.
15. Otsubo T, Iwaya K, Mukai Y, Mizokami Y, Serizawa H, Matsuoka T, Mukai K. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod Pathol 2004; 17: 461-7.
16. Zheng HC, Zheng YS, Li XH, Takahashi H, Hara T, Masuda S, Yang XH, Guan YF, Takano Y. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma. Anticancer Res 2008; 28(4B): 2225-32.
17. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, Ahn WS. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 2005; 99: 26-35.
18. Godbout R, Bisgrove DA, Shkolny D, Day RS 3rd. Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 1998; 16: 1955-62.
19. Custer RP, Sorof S. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes. Proc Natl Acad Sci U S A 1984; 81: 6738-42.
20. Das R, Hammamieh R, Neill R, Melhem M, Jett M. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 2001; 7: 1706-15.
21. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, Teh BT. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 2001; 98: 9754-9.
22. Teratani T, Domoto T, Kuriki K, Kageyama T, Takayama T, Ishikawa A, Ozono S, Nozawa R. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma. Urology 2007; 69: 236-40.
23. Kebache S, Cardin E, Nguyen DT, Chevet E, Larose L. Nck-1 antagonizes the endoplasmic reticulum stress-induced inhibition of translation. J Biol Chem 2004; 279: 9662-71.
24. Cardin E, Larose L. Nck-1 interacts with PKR and modulates its activation by dsRNA. Biochem Biophys Res Com 2008; 377: 231-5.
25. Mauri P, Scarpa A, Nascimbeni AC, Benazzi L, Parmagnani E, Mafficini A, Della Peruta M, Bassi C, Miyazaki K, Sorio C. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 2005; 19: 1125-7.
26. Whitcomb DC, Preston RA, Aston CE, Sossenheimer MJ, Barua PS, Zhang Y, Wong-Chong A, White GJ, Wood PG, Gates LK J, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996; 110: 1975-80.
27. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphor-ylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7: 331-42.
28. Bahnassy AA, Zekri AR, Saleh M, Lotayef M, Moneir M, Shawki O. The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma. BMC Clin Pathol 2007; 7: 4.
29. Nichols GE, Williams ME, Gaffey MJ, Stoler MH. Cyclin D1 gene expression in human cervical neoplasia. Mod Pathol 1996; 9: 418-25.